100700 — Sewoon Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩136bn
- KR₩63bn
- KR₩68bn
- 97
- 75
- 42
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 17,231 | 13,337 | 16,626 | 13,629 | 19,298 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -2,542 | 3,128 | -716 | -805 | -1,184 |
Discontinued Operations | |||||
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5,077 | -898 | 1,723 | -7,434 | 1,314 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13,109 | 19,252 | 21,469 | 9,279 | 23,076 |
Capital Expenditures | -5,960 | -3,488 | -2,489 | -2,168 | -1,956 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 353 | 958 | -6,687 | -17,653 | 25,598 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5,608 | -2,530 | -9,177 | -19,821 | 23,642 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4,771 | -2,316 | -2,440 | -2,462 | -2,893 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,715 | 14,293 | 10,213 | -12,849 | 43,707 |